The weekly litigation news digest is live. Subscribe now

Pharmaceutical Composition Comprising Hmg-Coa Reductase Inhibitors And Fenofibrate - EP3833335

The patent EP3833335 was granted to Intas Pharmaceuticals on Aug 31, 2022. The application was originally filed on Jul 30, 2020 under application number EP20764155A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3833335

INTAS PHARMACEUTICALS
Application Number
EP20764155A
Filing Date
Jul 30, 2020
Status
Granted And Under Opposition
Jul 29, 2022
Publication Date
Aug 31, 2022
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

VIATRIS HEALTHCARE LDAJun 5, 2024ELKINGTON AND FIFEINTERVENTION WITHDRAWN
ELKINGTON AND FIFEMay 30, 2023ELKINGTON AND FIFEWITHDRAWN

Patent Citations (19) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONEP0330532
DESCRIPTIONEP0521471
DESCRIPTIONEP1185274
DESCRIPTIONEP1853249
DESCRIPTIONEP2306982
DESCRIPTIONGB1415295
DESCRIPTIONUS2011311625
DESCRIPTIONUS6277405
DESCRIPTIONUSRE37314E
DESCRIPTIONWO2005034908
DESCRIPTIONWO2005034920
DESCRIPTIONWO2008075320
INTERNATIONAL-SEARCH-REPORTWO2008075320
OPPOSITIONEP0330532
OPPOSITIONUS2002009496
OPPOSITIONUS2005096391
OPPOSITIONUS4895726
OPPOSITIONUS6074670
OPPOSITIONWO2008075320

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents